Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Wuxi Biologics ADR (WXXWY)

Wuxi Biologics ADR (WXXWY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™，to Accelerate Biologics Development with High Titer and Superior Stability PR Newswire - Thu Sep 25, 2025

SHANGHAI , Sept. 25, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch...

WXXWY : 9.2850 (+2.03%)
WuXi Biologics Selected as Constituent of FTSE4Good Index Series for Fifth Consecutive Year PR Newswire - Mon Sep 22, 2025

SHANGHAI , Sept. 23, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been...

WXXWY : 9.2850 (+2.03%)
Three WuXi Biologics Manufacturing Facilities Receive GMP Certification from Türkiye İlaç ve Tıbbi Cihaz Kurumu (TITCK) PR Newswire - Tue Sep 16, 2025

WUXI, China , Sept. 17, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three...

WXXWY : 9.2850 (+2.03%)
WuXi Biologics Achieves "CDMO of the Year" Among Three Prestigious IMAPAC Awards PR Newswire - Thu Sep 11, 2025

SINGAPORE , Sept. 11, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that it has received...

WXXWY : 9.2850 (+2.03%)
WuXi Biologics Launches Green CRDMO White Paper to Advance Sustainability in Biologics Industry PR Newswire - Tue Sep 9, 2025

SHANGHAI , Sept. 9, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), recently launched the "WuXi...

WXXWY : 9.2850 (+2.03%)
WuXi Biologics' Near-Term and Net-Zero Targets Approved by SBTi PR Newswire - Thu Aug 28, 2025

SHANGHAI , Aug. 28, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced its near-term...

WXXWY : 9.2850 (+2.03%)
WuXi Biologics Reports Solid 2025 Interim Results PR Newswire - Tue Aug 19, 2025

HONG KONG , Aug. 19, 2025 /PRNewswire/ -- WuXi Biologics (Cayman) Inc. ("WuXi Biologics" or "the Group", stock code: 2269.HK), a leading global Contract Research, Development and Manufacturing...

WXXWY : 9.2850 (+2.03%)
WuXi Biologics' WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale PR Newswire - Tue Aug 12, 2025

SHANGHAI , Aug. 12, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that its intensified...

WXXWY : 9.2850 (+2.03%)
WuXi Biologics' WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale PR Newswire - Tue Aug 12, 2025

SHANGHAI , Aug. 12, 2025 /CNW/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that its intensified...

WXXWY : 9.2850 (+2.03%)
WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules PR Newswire - Mon Aug 11, 2025

SHANGHAI , Aug. 11, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of...

WXXWY : 9.2850 (+2.03%)

Barchart Exclusives

S&P Futures Muted as Middle East Conflict Uncertainty Persists, U.S. Inflation Data in Focus Barchart - 24 minutes ago
March S&P 500 E-Mini futures (ESH26) are trending up +0.03% this morning, fluctuating after erasing earlier gains as uncertainty surrounding the Middle East conflict remains high, while investors await key U.S. inflation data. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot